Clinical Trials Logo

Clinical Trial Summary

The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise morbidity and mortality. The literature identifies the leak rate for colorectal operations as 3-39%.


Clinical Trial Description

Introduction: The use of regenerative medicine in colorectal surgery constitutes an entirely new therapeutic principle. The aim of this new therapeutic approach is to reduce the anastomotic leak rate and minimise morbidity and mortality. The literature identifies the leak rate for colorectal operations as 3-39%. Methods: This is a prospective, multi-centre descriptive study commencing in June 2018. As part of the elective laparoscopic colorectal surgery, an autologous fibrin matrix was used as part of anastomotic technique in conjunction with activated thrombocytes (Obsidian ASG®). During anastomosis, this matrix was applied after resection onto the colorectal tissue surfaces with the aim of triggering tissue regeneration and improved wound healing. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04386148
Study type Observational
Source Kepler University Hospital
Contact
Status Completed
Phase
Start date June 1, 2018
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05250882 - Enhanced Perioperative Care for the Prevention of Colorectal Anastomotic Leakage N/A
Recruiting NCT05411783 - Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial N/A
Completed NCT04761536 - Volume-outcome Relationship in Rectal Cancer Surgery
Recruiting NCT06273826 - "Colorectal Leakage App" for Early Detection of Anastomotic Leakage After Colorectal Surgeries
Recruiting NCT05810207 - A1Check: the External Validation of a Machine Learning Model Predicting Colorectal Anastomotic Leakage
Recruiting NCT05174910 - Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery N/A
Completed NCT05293054 - Healing of Rectal Anastomosis Sealed With a Concentrate Derived From the Patient's Blood, After Rectal Cancer Surgery
Not yet recruiting NCT05610904 - Evaluation of AL Prediction for Rectal Cancer N/A
Completed NCT06180564 - Comparison of Rates of Anastomotic Leak in Patients Undergoing Colo-rectal Surgery When Bowel Perfusion and Resection Margin is Deterimined by Intra-operative Infra-red Thermography or by Conventional Method N/A
Not yet recruiting NCT04127734 - Treatment of Anastomotic Leakage After Rectal Cancer Resection